SARTORIUS AG

About SARTORIUS AG

Michael Grosse is a German industrial executive known for his expertise in operational transformation, international leadership and the management of technology businesses serving the pharmaceutical and food sectors. He was appointed Chief Executive Officer of Sartorius AG as Joachim Kreuzburg’s successor, with the transition announced in 2025. He also became Chairman of the Board of Sartorius Stedim Biotech S.A., the group’s listed French subsidiary, placing him at the center of Sartorius’ corporate governance structure. Before joining Sartorius, Michael Grosse held senior leadership roles in process and packaging equipment businesses. From 2020 to 2023, he served as Chairman of the Management Board and CEO of Syntegon Technology GmbH, an international provider of process and packaging solutions carved out of Bosch’s operations. Prior to that, he spent many years at Tetra Pak, where he became a member of the Executive Board in 2006 and was responsible for expanding the global service business, alongside various product development responsibilities. His career began in the automotive industry, including positions at BMW and Ford, giving him a strong foundation in industrial excellence, scaling operations and managing complex transformations. At Sartorius, Grosse operates within a group strongly focused on bioprocessing, high-margin consumables and solutions for biopharmaceutical manufacturing. His appointment as CEO of Sartorius AG and Chairman of Sartorius Stedim Biotech reflects a desire for strategic continuity, closer alignment between the parent company and the French listed subsidiary, and reinforced global oversight. His profile is especially well suited to an environment that combines innovation, industrial expansion, financial discipline and public-company governance. He brings relevant experience in complex value chains, B2B customer relationships, international growth and industrial capacity optimization.